documents: FDA-2016-N-3389-0100
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-3389-0100 | FDA | FDA-2016-N-3389 | Reference 02-96 Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus a randomized-controlled clinical trial re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:09:26Z | 0 | 0 | 09000064823994e2 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref